Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer

Despite recent advances in the treatment of non-small cell lung cancer (NSCLC), less than 10% of patients survive the first five years when the disease has already spread at primary diagnosis. Methods: Blood samples were taken from 118 NSCLC patients at primary diagnosis or at progression of the dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Obermayr, Eva, Koppensteiner, Nina, Heinzl, Nicole, Schuster, Eva, Holzer, Barbara, Fabikan, Hannah, Weinlinger, Christoph, Illini, Oliver, Hochmair, Maximilian, Zeillinger, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620949/
https://www.ncbi.nlm.nih.gov/pubmed/34834576
http://dx.doi.org/10.3390/jpm11111225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620949/
https://www.ncbi.nlm.nih.gov/pubmed/34834576
http://dx.doi.org/10.3390/jpm11111225

Ejemplares similares